The Partnering Agreements with Intermune 2005-2013 report provides an in-depth
insight into the partnering interests and activities of one of the worlds
leading biopharma companies.
This
report provides all the information you require to better understand Intermune
and its partnering interests and activities over the past seven years.
To
Read The Complete Report with TOC :-
On
demand company reports are prepared upon purchase to ensure inclusion of the
most up to date deal and company data.
One
of the key aspects of partnering is finding those companies that are potential
partners for the development and commercialization of the next generation of
therapies as developed by innovative biopharma R&D companies. A lot of
resources are spent on finding partners, identifying their interests and making
contact to initiate discussions.
Using
this report, dealmakers will effectively and efficiently target their
partnering activities to deliver the company’s business development objectives.
The
initial chapters of this report provide an orientation of bigpharma’s
dealmaking and business activities.
Chapter
1 provides an
introduction to the report, whilst
Chapter
2 lists the top 50
leading biopharma companies based on 2010 pharmaceutical revenues and their
respective partnering activity.
Chapter
3 provides
an overview of the leading partnering and M&A 2005 to present date based on
headline value.
Chapter
4 provides details
on how to approach bigpharma companies with partnering opportunities
whilst
Chapter
5 lists forthcoming
partnering events and conferences where bigpharma companies will be present to
discuss opportunities face to face.
The
main body of the report is provided in chapter 6. A profile of the company
provides everything required to assess the suitability of a company as a
prospective partner. This includes a company overview, partnering interests,
partnering activity according to deal type, industry sector, phase of
development, and therapy area. The profile also includes in-depth contact
information for individuals within the business development function.
To Buy a Copy Of This Report:-
Understanding
the flexibility of prospective partners’ negotiated deals terms provides
critical insight into the negotiation process in termsof what you can expect to
achieve during the negotiation of terms. Whilst many smaller companies will be
seeking details of the payments clauses, the devil is in the detail in terms of
how payments are triggered – contract documents provide this insight where
press releases and databases do not.
In
summary, the report provides the user with the tools to make successful contact
with the right partners effectively and efficiently.
Contact
M/s Sheela
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-997-4948
No comments:
Post a Comment